Relay Therapeutics, Inc. (RLAY)
19.76
+0.32
(+1.65%)
USD |
NASDAQ |
Aug 24, 16:00
19.76
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics 1 Year Total Returns (Daily) : 470.1% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 470.1% |
| August 20, 2026 | 479.4% |
| August 19, 2026 | 510.0% |
| August 18, 2026 | 493.9% |
| August 17, 2026 | 483.9% |
| August 14, 2026 | 485.8% |
| August 13, 2026 | 482.7% |
| August 12, 2026 | 499.1% |
| August 11, 2026 | 515.1% |
| August 10, 2026 | 519.3% |
| August 07, 2026 | 466.5% |
| August 06, 2026 | 459.5% |
| August 05, 2026 | 457.8% |
| August 04, 2026 | 435.3% |
| August 03, 2026 | 458.9% |
| July 31, 2026 | 434.9% |
| July 30, 2026 | 435.8% |
| July 29, 2026 | 407.5% |
| July 28, 2026 | 394.3% |
| July 27, 2026 | 398.4% |
| July 24, 2026 | 401.1% |
| July 23, 2026 | 403.7% |
| July 22, 2026 | 419.4% |
| July 21, 2026 | 431.7% |
| July 20, 2026 | 448.0% |
| Date | Value |
|---|---|
| July 17, 2026 | 445.5% |
| July 16, 2026 | 432.1% |
| July 15, 2026 | 457.4% |
| July 14, 2026 | 436.0% |
| July 13, 2026 | 420.3% |
| July 10, 2026 | 436.3% |
| July 09, 2026 | 444.6% |
| July 08, 2026 | 446.8% |
| July 07, 2026 | 456.1% |
| July 06, 2026 | 420.7% |
| July 02, 2026 | 418.1% |
| July 01, 2026 | 404.5% |
| June 30, 2026 | 440.8% |
| June 29, 2026 | 498.2% |
| June 26, 2026 | 459.0% |
| June 25, 2026 | 446.9% |
| June 24, 2026 | 444.4% |
| June 23, 2026 | 439.9% |
| June 22, 2026 | 441.7% |
| June 18, 2026 | 372.6% |
| June 17, 2026 | 408.5% |
| June 16, 2026 | 360.2% |
| June 15, 2026 | 364.6% |
| June 12, 2026 | 329.3% |
| June 11, 2026 | 326.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Insmed, Inc. | -5.15% |
| United Therapeutics Corp. | 65.17% |
| AbbVie, Inc. | 30.40% |
| TG Therapeutics, Inc. | 88.63% |
| Travere Therapeutics, Inc. | 269.4% |